Drug intelligence / Profile preview

acellular corneal stroma

Development stage
Unknown
Lead developer
Regenerative Medical Technologies
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Surgical Implantation, Ophthalmic, Intracorneal
01

Overview

Acellular corneal stroma is a tissue-engineered biomaterial derived from the extracellular matrix of porcine (pig) corneas through processes that remove cellular components and inactivate viruses. The main component is collagen, which preserves the natural fiber structure and transparency of human cornea. It serves as a scaffold for host cell migration and integration when used as a graft in lamellar keratoplasty or other forms of corneal transplantation. Its primary mechanism is to provide physical coverage and support for regeneration by promoting epithelial healing and stromal matrix synthesis while maintaining low immunogenicity due to decellularization. Acellular porcine corneal stroma has been shown to be an effective alternative to human donor tissue for treating conditions such as infectious keratitis, deep stromal defects, descemetocele, perforations, and non-healing ulcers[4][5][6][7][9]. Clinical studies demonstrate good biocompatibility, mechanical stability similar to native human tissue, rapid epithelial recovery (typically within 1 week), low rates of rejection or infection with proper management, and restoration of visual acuity in most patients[4][7]. It can also serve as a carrier for cell-based therapies or endothelial sheet engineering[8].

Brand names
ACORNEABioCorneaVet
Other names
acellular porcine corneal stromaAPCSacellular corneal stroma matrix

Beyond the preview

Go deeper on acellular corneal stroma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acellular corneal stroma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call